No, they
have made 3 clinical studies
25% is not a random number, this is on the puretech paper. So please, read it before writing something about me
The data are secretive. You can't find the results or Follica's clinical trials listed anywhere. You don't understand that ?? liked you don't understand that a patent could be published many years after the filling date ? Sigh
"
Follica’s three clinical studies of patients with androgenetic alopecia demonstrated hair growth
through target area hair count and/or hair follicle neogenesis through biopsy following TCP. Follica
views TCP as a foundational technique which could potentially be enhanced through the addition of
drugs. One of the three studies was a two arm study in which one arm received TCP plus placebo and
the other arm received TCP plus a drug which was being used in an exploratory manner to see if it
could enhance TCP. Both arms showed a statistically significant increase in hair growth
(a combination of vellus and terminal hair), but TCP enhanced hair growth to the same degree with or
without that particular drug, and therefore the study did not meet its primary endpoint. This resulted
in an impairment loss for PureTech with respect to its holding in Follica. PureTech subsequently led a
recapitalisation of Follica in 2013 pursuant to which PureTech gained control of Follica and also
obtained future royalties on net product sales".